Literature DB >> 12355487

Long-term outcome in patients with juvenile idiopathic arthritis.

Kirsten Minden1, Martina Niewerth, Joachim Listing, Thomas Biedermann, Matthias Bollow, Monika Schöntube, Angela Zink.   

Abstract

OBJECTIVE: To describe the long-term outcome of juvenile idiopathic arthritis (JIA).
METHODS: All patients with JIA referred to a pediatric rheumatology center between 1978 and 1988 were identified and invited to undergo an assessment. Patients with JIA from a population-based cohort from East Berlin were included. The outcome assessment considered changes in body function and structure (e.g., mortality, joint abnormalities, disease activity), activities at the individual level (Health Assessment Questionnaire), and participation in society (e.g., mobility, educational and vocational background).
RESULTS: Of 260 eligible patients, 215 (83%) were evaluated. Subtypes of JIA at disease onset included oligoarthritis (40%), polyarthritis (14%), systemic arthritis (14%), psoriatic arthritis (1%), enthesitis-related arthritis (15%), and other arthritis (16%). Followup was conducted after a median of 16.5 years. No deaths occurred in this cohort. At followup, approximately half of the patients had active disease and/or changes in body structures to a variable extent. Approximately one-third of patients rated themselves as being functionally limited. Patients demonstrated good social integration: few mobility problems were reported, and the educational achievements of patients were higher and their rate of unemployment was lower compared with the age-matched population. No significant differences in outcome were found between the population-based and the referral-based cohorts.
CONCLUSION: Even though approximately half of the JIA patients had more or less distinctive changes in body function and/or structure after a disease duration of >15 years, fewer than 10% were severely disabled or handicapped. Because JIA often persists into adulthood, long-term followup and care are necessary.

Entities:  

Mesh:

Year:  2002        PMID: 12355487     DOI: 10.1002/art.10444

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  102 in total

Review 1.  [Malignancy and tumor necrosis factor inhibitors in juvenile idiopathic arthritis].

Authors:  G Horneff
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

2.  Enthesitis-related arthritis: time to re-define?

Authors:  Angela R Bryan; C Egla Rabinovich
Journal:  Curr Rheumatol Rep       Date:  2014-12       Impact factor: 4.592

3.  [Rheumatic joint disease in childhood and adolescence].

Authors:  C Rietschel; K Latta
Journal:  Orthopade       Date:  2012-03       Impact factor: 1.087

4.  Prominent midfoot involvement in children with enthesitis-related arthritis category of juvenile idiopathic arthritis.

Authors:  Sanat Phatak; Namita Mohindra; Abhishek Zanwar; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2017-06-20       Impact factor: 2.980

5.  [Transition clinic--it is not always a simple segue in rheumatology for adults].

Authors:  K Minden; M Niewerth; A Zink; G Ganser
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

6.  Population-based study of outcomes of patients with juvenile idiopathic arthritis (JIA) compared to non-JIA subjects.

Authors:  Megan L Krause; Jorge A Zamora-Legoff; Cynthia S Crowson; Theresa Wampler Muskardin; Thomas Mason; Eric L Matteson
Journal:  Semin Arthritis Rheum       Date:  2016-07-18       Impact factor: 5.532

7.  [Biologics register JuMBO. Long-term safety of biologic therapy of juvenile idiopathic arthritis].

Authors:  K Minden; J Klotsche; M Niewerth; G Horneff; A Zink
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

8.  Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept.

Authors:  M Halbig; G Horneff
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

9.  [Therapy of juvenile idiopathic arthritis in early adulthood with biologics: transition from pediatric to adult care].

Authors:  M Niewerth; K Minden; J Klotsche; G Horneff
Journal:  Z Rheumatol       Date:  2014-08       Impact factor: 1.372

10.  Caregiver demand and parent distress in juvenile rheumatic disease: the mediating effect of parent attitude toward illness.

Authors:  Jamie L Ryan; Larry L Mullins; Rachelle R Ramsey; Margaret S Bonner; James N Jarvis; Stephen R Gillaspy; John M Chaney
Journal:  J Clin Psychol Med Settings       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.